Orbimed Advisors LLC Chemomab Therapeutics Ltd. Transaction History
Orbimed Advisors LLC
- $2.8 Billion
- Q2 2025
A detailed history of Orbimed Advisors LLC transactions in Chemomab Therapeutics Ltd. stock. As of the latest transaction made, Orbimed Advisors LLC holds 940,990 shares of CMMB stock, worth $865,710. This represents 0.04% of its overall portfolio holdings.
Number of Shares
940,990
Previous 1,741,273
45.96%
Holding current value
$865,710
Previous $1.9 Million
42.49%
% of portfolio
0.04%
Previous 0.06%
Shares
5 transactions
Others Institutions Holding CMMB
# of Institutions
14Shares Held
4.22MCall Options Held
0Put Options Held
0-
Morgan Stanley New York, NY1.61MShares$1.49 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L3738KShares$679,0040.24% of portfolio
-
Yelin Lapidot Holdings Management Ltd. Tel Aviv, L3578KShares$532,0270.12% of portfolio
-
Ikarian Capital, LLC Dallas, TX213KShares$196,0070.08% of portfolio
-
Rhumbline Advisers Boston, MA39.9KShares$36,6850.0% of portfolio
About Chemomab Therapeutics Ltd.
- Ticker CMMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,431,700
- Market Cap $10.5M
- Description
- Chemomab Therapeutics Ltd., a clinical-stage biotech company, discovers and develops therapeutics for the treatment of inflammation and fibrosis. The company's lead clinical product candidate is CM-101, a humanized monoclonal antibody that hinders the basic function of soluble chemokine CCL24 for the treatment of primary sclerosing cholangitis (...